Affordable Access

Access to the full text

Hypoketotic hypoglycemia in citrin deficiency: a case report

Authors
  • Wada, Yoichi1
  • Arai-Ichinoi, Natsuko1
  • Kikuchi, Atsuo1
  • Sakamoto, Osamu1
  • Kure, Shigeo1, 2
  • 1 Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, Miyagi, 980-8574, Japan , Sendai (Japan)
  • 2 Tohoku Medical Megabank Organization, 2-1, Seiryomachi, Aobaku, Sendai, Miyagi, 980-8573, Japan , Sendai (Japan)
Type
Published Article
Journal
BMC Pediatrics
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 22, 2020
Volume
20
Issue
1
Identifiers
DOI: 10.1186/s12887-020-02349-6
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundCitrin deficiency (CD) is a recessive metabolic disease caused by biallelic pathogenic variants in SLC25A13. Although previous studies have reported ketosis in CD, it was observed at the time of euglycemia or mild hypoglycemia. Blood ketone levels concomitant with symptomatic or severe hypoglycemia in CD have not been a topic of focus despite its importance in identifying the etiology of hypoglycemia and assessing the ability of fatty acid utilization. Herein, we describe a patient with CD who had repeated episodes of hypoglycemia with insufficient ketosis.Case presentationA 1-year-old boy with repetitive hypoglycemia was referred to us to investigate its etiology. The fasting load for 13 h led to hypoketotic hypoglycemia, indicating the possibility of partial β-oxidation dysfunction. A genetic test led to the diagnosis of CD. The hypoglycemic episodes disappeared after switching to a medium-chain triglyceride-containing formula.ConclusionsThis case report suggests that symptomatic or severe hypoglycemia in patients with CD could be associated with relatively low levels of ketone bodies, implying that β-oxidation in these patients might possibly be partially disrupted. When encountering a patient with hypoglycemia, clinicians should check blood ketone levels and bear in mind the possibility of CD because excessive intravenous administration of glucose can cause decompensated symptoms in patients with CD as opposed to other disorders presenting with hypoketotic hypoglycemia, such as fatty acid oxidation disorders. Further studies in a large-scale cohort are warranted to confirm our speculation.

Report this publication

Statistics

Seen <100 times